Page last updated: 2024-08-21

quinazolines and er-086526

quinazolines has been researched along with er-086526 in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Dean-Colomb, W; Esteva, FJ	1
Garzon, F; Geater, SL; Gopalakrishna, P; Iannotti, N; Lee, V; Lim, WT; Mok, TS; Reyderman, L; Reynolds, C; Smith, D; Spira, A; Thongprasert, S; Wang, B; Xu, L	1
Casanova, C; Dazzi, C; Mazza, V; Verlicchi, A	1
Goto, H; Goto, S; Hamanoue, S; Inukai, T; Ito, M; Iwasaki, F; Keino, D; Kumamoto, T; Miyagawa, N; Nagai, J; Sakurai, Y; Shiomi, M; Yokosuka, T; Yoshino, Y	1

Reviews

1 review(s) available for quinazolines and er-086526

Article	Year
Emerging agents in the treatment of anthracycline- and taxane-refractory metastatic breast cancer. Seminars in oncology, 2008, Volume: 35, Issue:2 Suppl 2 Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Clinical Trials as Topic; Deoxycytidine; Dioxoles; Diphtheria Toxin; Drug Resistance, Neoplasm; Drugs, Investigational; Epothilones; Female; Furans; Gemcitabine; Glutamates; Guanine; Humans; Interleukin-2; Ketones; Lapatinib; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Pemetrexed; Quinazolines; Recombinant Fusion Proteins; Tetrahydroisoquinolines; Trabectedin; Vinblastine; Vinorelbine	2008

Article

Year

Emerging agents in the treatment of anthracycline- and taxane-refractory metastatic breast cancer.

Seminars in oncology, 2008, Volume: 35, Issue:2 Suppl 2

Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Clinical Trials as Topic; Deoxycytidine; Dioxoles; Diphtheria Toxin; Drug Resistance, Neoplasm; Drugs, Investigational; Epothilones; Female; Furans; Gemcitabine; Glutamates; Guanine; Humans; Interleukin-2; Ketones; Lapatinib; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Pemetrexed; Quinazolines; Recombinant Fusion Proteins; Tetrahydroisoquinolines; Trabectedin; Vinblastine; Vinorelbine

2008

Trials

1 trial(s) available for quinazolines and er-086526

Article	Year
Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Erlotinib Hydrochloride; Female; Furans; Humans; Ketones; Lung Neoplasms; Male; Middle Aged; Quinazolines	2014

Article

Year

Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:8

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Erlotinib Hydrochloride; Female; Furans; Humans; Ketones; Lung Neoplasms; Male; Middle Aged; Quinazolines

2014

Other Studies

2 other study(ies) available for quinazolines and er-086526

Article	Year
Benefit of eribulin in a patient with HER2(+) breast cancer who progressed after trastuzumab and lapatinib: a case report. Future oncology (London, England), 2015, Volume: 11, Issue:15 Suppl Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; Fatal Outcome; Female; Furans; Humans; Ketones; Lapatinib; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Quinazolines; Receptor, ErbB-2; Retreatment; Trastuzumab	2015
Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia. Cancer chemotherapy and pharmacology, 2020, Volume: 85, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Aurora Kinase A; Cell Cycle; Cell Proliferation; Docetaxel; Drug Therapy, Combination; Furans; High-Throughput Screening Assays; Humans; Ketones; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Quinazolines; Tumor Cells, Cultured; Vincristine	2020

Article

Year

Benefit of eribulin in a patient with HER2(+) breast cancer who progressed after trastuzumab and lapatinib: a case report.

Future oncology (London, England), 2015, Volume: 11, Issue:15 Suppl

Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; Fatal Outcome; Female; Furans; Humans; Ketones; Lapatinib; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Quinazolines; Receptor, ErbB-2; Retreatment; Trastuzumab

2015

Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia.

Cancer chemotherapy and pharmacology, 2020, Volume: 85, Issue:4

Topics: Antineoplastic Combined Chemotherapy Protocols; Aurora Kinase A; Cell Cycle; Cell Proliferation; Docetaxel; Drug Therapy, Combination; Furans; High-Throughput Screening Assays; Humans; Ketones; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Quinazolines; Tumor Cells, Cultured; Vincristine

2020